This company has been marked as potentially delisted and may not be actively trading. NYSE:BMR Biomed Realty Trust (BMR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsHeadlinesOwnershipTrendsBuy This Stock About Biomed Realty Trust Stock (NYSE:BMR) 30 days 90 days 365 days Advanced Chart Get Biomed Realty Trust alerts:Sign Up Key Stats Today's Range$2.85▼$2.9550-Day Range N/A52-Week Range$17.94▼$25.08Volume202,879 shsAverage Volume3.29 million shsMarket Capitalization$37.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet. Read More Receive BMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biomed Realty Trust and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BMR Stock News HeadlinesBiomed Realty Tr (BMR)April 16, 2025 | uk.investing.comBeamr to Present at the Loop Capital Markets 2025 Investor ConferenceMarch 10, 2025 | globenewswire.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.September 13 at 2:00 AM | Porter & Company (Ad)Beamr Issues Annual CEO Letter to Shareholders: Highlighting 2024 Achievements and 2025 Strategy - Capitalizing on Market ValidationMarch 4, 2025 | globenewswire.comBeamr to Discuss How AI Revolutionizes the Video Industry at NVIDIA GTCFebruary 27, 2025 | globenewswire.comBeamr Strengthens Partnership with AWS by Joining AWS ISV Accelerate: a Global Co-Sell ProgramFebruary 18, 2025 | globenewswire.comBeamr to Present at the A.G.P.'s Virtual Technology ConferenceFebruary 11, 2025 | globenewswire.comBeamr CEO will Present a Keynote Speech at the ACM Mile-High-Video 2025February 10, 2025 | globenewswire.comSee More Headlines BMR Stock Analysis - Frequently Asked Questions How were Biomed Realty Trust's earnings last quarter? Biomed Realty Trust Inc (NYSE:BMR) posted its earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.04. The company's revenue for the quarter was up 5.4% on a year-over-year basis. When did Biomed Realty Trust IPO? Biomed Realty Trust (BMR) raised $8 million in an initial public offering (IPO) on Tuesday, February 28th 2023. The company issued 1,950,000 shares at $4.00 per share. What other stocks do shareholders of Biomed Realty Trust own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biomed Realty Trust investors own include NVIDIA (NVDA), Tesla (TSLA), Ford Motor (F), Meta Platforms (META), Broadcom (AVGO), Norwegian Cruise Line (NCLH) and NIO (NIO). Company Calendar Last Earnings4/28/2015Today9/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Discretionary Industry Prepackaged software Sub-IndustryOffice REITs Current SymbolNYSE:BMR CIK1289236 Webwww.biomedrealty.com Phone+1-858-4859840FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.02 Current Ratio6.70 Quick Ratio6.70 Sales & Book Value Annual Sales$2.91 million Price / Sales12.88 Cash FlowN/A Price / Cash FlowN/A Book Value$0.80 per share Price / Book3.64Miscellaneous Outstanding Shares12,880,000Free FloatN/AMarket Cap$37.48 million OptionableNot Optionable Beta5.22 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NYSE:BMR) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomed Realty Trust Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomed Realty Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
